Pages that link to "Q72243325"

The following pages link to Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes (Q72243325):

Displaying 29 items.

• Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain (Q28820780) (← links)
• Acetyl-L-carnitine in diabetic polyneuropathy: experimental and clinical data (Q31121713) (← links)
• Acetyl-L-carnitine in neuropathic pain: experimental data. (Q31121719) (← links)
• Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. (Q33788671) (← links)
• Acetyl-L-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury (Q33965418) (← links)
• How does glucose generate oxidative stress in peripheral nerve? (Q34146338) (← links)
• The role of taurine in diabetes and the development of diabetic complications (Q34465081) (← links)
• Neuromuscular complications in endocrine and metabolic disorders (Q34489371) (← links)
• Polyol pathway and diabetic peripheral neuropathy (Q34800429) (← links)
• Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity. (Q34804920) (← links)
• Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine (Q34997110) (← links)
• Acetyl-L-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery. (Q35980880) (← links)
• Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. (Q36571464) (← links)
• Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors (Q36841926) (← links)
• L-acetylcarnitine: a proposed therapeutic agent for painful peripheral neuropathies (Q37211777) (← links)
• Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications (Q37373683) (← links)
• Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model. (Q37751655) (← links)
• Neurological damage in MSUD: the role of oxidative stress. (Q38162092) (← links)
• Protective effects of acetyl-L-carnitine on cisplatin cytotoxicity and oxidative stress in neuroblastoma (Q39784228) (← links)
• Diabetes and the nervous system (Q41107228) (← links)
• Early oxidative stress in the diabetic kidney: effect of DL-alpha-lipoic acid (Q44274282) (← links)
• The effect of L-carnitine on the prevention of experimentally induced myringosclerosis in rats (Q44614465) (← links)
• L-carnitine blood levels and oxidative stress in treated phenylketonuric patients (Q46349805) (← links)
• Neurovascular effects of l-carnitine treatment in diabetic rats (Q63453660) (← links)
• The effects of acetyl-L-carnitine and sorbinil on peripheral nerve structure, chemistry, and function in experimental diabetes (Q71220031) (← links)
• Attenuation of acrylamide-induced neurotoxicity in diabetic rats (Q73661254) (← links)
• Nerve function and oxidative stress in diabetic and vitamin E-deficient rats (Q74069324) (← links)
• Nerve conduction and antioxidant levels in experimentally diabetic rats: effects of streptozotocin dose and diabetes duration (Q77334266) (← links)
• Effects of L-carnitine on oxidant/antioxidant status in acetic acid-induced colitis (Q83155187) (← links)